Steward Partners Investment Advisory’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.24M | Buy |
128,180
+79,700
| +164% | +$1.39M | 0.02% | 684 |
|
|
2025
Q1 | $610K | Buy |
48,480
+10,430
| +27% | +$131K | 0.01% | 1132 |
|
|
2024
Q4 | $401K | Buy |
38,050
+12,200
| +47% | +$129K | ﹤0.01% | 1265 |
|
|
2024
Q3 | $375K | Buy |
25,850
+24,650
| +2,054% | +$357K | ﹤0.01% | 1237 |
|
|
2024
Q2 | $10.2K | Sell |
1,200
-100
| -8% | -$851 | ﹤0.01% | 2814 |
|
|
2024
Q1 | $13.3K | Hold |
1,300
| – | – | ﹤0.01% | 2699 |
|
|
2023
Q4 | $7.12K | Hold |
1,300
| – | – | ﹤0.01% | 2832 |
|
|
2023
Q3 | $4.91K | Hold |
1,300
| – | – | ﹤0.01% | 2835 |
|
|
2023
Q2 | $8.71K | Buy |
1,300
+100
| +8% | +$670 | ﹤0.01% | 2618 |
|
|
2023
Q1 | $7.81K | Buy |
+1,200
| New | +$7.81K | ﹤0.01% | 2634 |
|